Stability of diluted chlorhexidine for skin testing in drug allergy evaluations
For CHX skin testing, SWFI is the preferred diluent at concentrations higher than 0.02 mg/mL to avoid precipitation. Using NS for the final dilution from 0.02 to 0.002 mg/mL is feasible and reduces injection pain. Except for CHX-NS at 5 mg/mL, reagents can be prepared up to 24 hours before testing.
Authors
- Sergio E. Chiarella (ORCID: https://orcid.org/0000-0002-0445-4929)
- Stacy D. Brown (ORCID: https://orcid.org/0000-0001-5566-1728)
- Hirohito Kita (ORCID: https://orcid.org/0000-0002-6854-2936)
- Gabriel Cojuc‐Konigsberg (ORCID: https://orcid.org/0000-0003-3463-6309)
- Alexei Gonzalez‐Estrada (ORCID: https://orcid.org/0000-0002-5754-6130)
- Divya Shah (ORCID: https://orcid.org/0000-0002-7190-8257)
- Gerald W. Volcheck
- Lene H. Garvey (ORCID: https://orcid.org/0000-0002-7777-4501)
Institutions
- East Tennessee State University (US)
- University of Copenhagen (DK)
- Mayo Clinic (US)
- University of Arizona (US)
- WinnMed (US)
- Gentofte Hospital (DK)
- Universidad Anáhuac (MX)
Publication Details
- Journal
- Journal of Allergy and Clinical Immunology Global
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1016/j.jacig.2024.100372
- Citations
- 3
- Primary Topic
- Contact Dermatitis and Allergies
- Type
- article
- Field-Weighted Citation Impact
- 1.60
Funders
- Arizona Department of Health Services